• Milestones Easier To Meet With Integrated Clinical Trials Management System

    Clinical Research News | Until recently, clinical study teams at the Medical University of South Carolina had no system for registering participants, keeping track of upcoming study visits, or what to invoice when on industry-sponsored projects. All that is changing with implementation of a clinical trials management system, fully integrated with the university’s Research Integrated Network of Systems, in mandatory use since March 2022 for all new trials undertaken across campus.

    Jul 14, 2022

  • Tufts Study Provides ‘First Hard Metrics’ Around Decentralized Clinical Trials

    Clinical Research News | Decentralized clinical trials can deliver a higher “expected net present value” that equates to a roughly $10 million return on a $2 million investment for phase 2 trials and $39 million return on a $3 million investment for phase 3 studies. The economic savings come from reduced cycle times, improved patient screening and enrollment, and fewer protocol amendments over the life of a trial.

    Jul 13, 2022

  • Worldwide Clinical Trial, Invitae Announce RWD Platform Partnership

    Clinical Research News | Worldwide Clinical Trials and Invitae have announced a strategic partnership. Worldwide will be the first CRO to use Invitae’s Explorer tool, part of its real-world data platform that enables access to aggregated genetic testing results.

    Jul 12, 2022

  • How the World’s First Clinical Trial Market Network Saves Stakeholders Time and Money

    Clinical Research News | ClinEco–a clinical trial ecosystem and market network designed to streamline the process of identifying and selecting clinical trial partners–is the first of its kind. It reduces the cost and speed of studies by catering to the specific needs of individual sponsors and vendors.

    Jul 12, 2022

  • Drug Repurposing Strategy Without An ‘Answer Book’

    Clinical Research News | Scientists working in the information biology lab at Hokkaido University in Japan have come up with a drug repurposing strategy combining machine learning, unsupervised clustering of gene expression, and two-stage prediction.

    Jul 7, 2022